These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 45088)

  • 1. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies with cefaclor, a new oral cephalosporin.
    Sanders C
    Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
    Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autobac I procedure to assess susceptibility to Cefaclor.
    Gröschel D; Mills K; Hopfer RL
    J Clin Microbiol; 1980 Jun; 11(6):660-3. PubMed ID: 7430335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 17. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of BMY-28100, a new oral cephalosporin.
    Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of oral cephalosporins (author's transl)].
    Wiedemann B; Flensberg T
    Infection; 1979; 7 Suppl 6():551-3. PubMed ID: 399247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.